AU2002301845A1 - Modified release tamsulosin tablets - Google Patents

Modified release tamsulosin tablets

Info

Publication number
AU2002301845A1
AU2002301845A1 AU2002301845A AU2002301845A AU2002301845A1 AU 2002301845 A1 AU2002301845 A1 AU 2002301845A1 AU 2002301845 A AU2002301845 A AU 2002301845A AU 2002301845 A AU2002301845 A AU 2002301845A AU 2002301845 A1 AU2002301845 A1 AU 2002301845A1
Authority
AU
Australia
Prior art keywords
modified release
release tamsulosin
tamsulosin tablets
tablets
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002301845A
Other versions
AU2002301845B2 (en
Inventor
Juan Cucala Escoi
Jacobus Maria Lemmens
Arturo Siles Ortega
Johannes J. Platteeuw
Frans Van Dalen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthon BV
Original Assignee
Synthon BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon BV filed Critical Synthon BV
Publication of AU2002301845A1 publication Critical patent/AU2002301845A1/en
Application granted granted Critical
Publication of AU2002301845B2 publication Critical patent/AU2002301845B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2002301845A 2001-11-07 2002-11-06 Modified release tamsulosin tablets Expired AU2002301845B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33105501P 2001-11-07 2001-11-07
US60/331,055 2001-11-07

Publications (2)

Publication Number Publication Date
AU2002301845A1 true AU2002301845A1 (en) 2003-06-12
AU2002301845B2 AU2002301845B2 (en) 2008-06-05

Family

ID=23292437

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002301845A Expired AU2002301845B2 (en) 2001-11-07 2002-11-06 Modified release tamsulosin tablets

Country Status (21)

Country Link
US (2) US20030147955A1 (en)
EP (3) EP1443917B1 (en)
JP (3) JP2005512997A (en)
CN (3) CN1298317C (en)
AT (3) ATE321544T1 (en)
AU (1) AU2002301845B2 (en)
CA (2) CA2465110A1 (en)
CZ (3) CZ16813U1 (en)
DE (4) DE60210315T2 (en)
DK (3) DK1443917T3 (en)
ES (2) ES2256544T3 (en)
HU (2) HUP0401978A3 (en)
IL (4) IL161491A0 (en)
NL (2) NL1021822C2 (en)
NO (2) NO20042374L (en)
NZ (2) NZ532589A (en)
PT (2) PT1443917E (en)
RU (2) RU2311903C2 (en)
SI (2) SI1443917T1 (en)
WO (2) WO2003039530A1 (en)
ZA (2) ZA200403281B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2311903C2 (en) * 2001-11-07 2007-12-10 Синтон Б.В. Tamzulosin tablets
US7018658B2 (en) * 2002-11-14 2006-03-28 Synthon Bv Pharmaceutical pellets comprising tamsulosin
IN192381B (en) * 2002-12-20 2004-04-10 Ranbaxy Lab
US20040253309A1 (en) * 2003-01-27 2004-12-16 Yamanouchi Pharmaceutical Co., Ltd. Enteric sustained-release fine particles of tamsulosin and its salt and manufacturing method thereof
EP1638537A1 (en) * 2003-07-01 2006-03-29 KRKA, tovarna zdravil, d.d., Novo mesto Tamsulosin core with a coating of polyvinylpyrrolidone and polyvinylacetate
KR100762846B1 (en) * 2003-09-29 2007-10-04 씨제이 주식회사 Sustained-release formulations
US20070122480A1 (en) * 2003-09-29 2007-05-31 Cj Corporation Sustained release formulations
JP2005104914A (en) * 2003-09-30 2005-04-21 Kyowa Yakuhin Kogyo Kk Basic agent-containing pharmaceutical preparation
JP2005162736A (en) * 2003-11-10 2005-06-23 Astellas Pharma Inc Sustained release medicinal composition
JP2005162737A (en) * 2003-11-10 2005-06-23 Astellas Pharma Inc Sustained release medicinal composition
US8197846B2 (en) * 2003-11-10 2012-06-12 Astellas Pharma Inc. Sustained release pharmaceutical composition
US8128958B2 (en) * 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
AU2003286415A1 (en) * 2003-12-03 2005-06-24 Natco Pharma Limited An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation
SI21702A (en) * 2004-01-29 2005-08-31 Lek Farmacevtska Druzba Dd Preparation of amorphous form of tamsulosin
JP4603803B2 (en) * 2004-01-30 2010-12-22 大洋薬品工業株式会社 Controlled release pharmaceutical composition and formulation using the same
PL204079B1 (en) * 2004-08-12 2009-12-31 Inst Farmaceutyczny Oral solid tamsulozine hydrochloride preparation with prolonged release and method for its manufacture
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
US20060160852A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Composition containing anti-dementia drug
US8481565B2 (en) 2004-12-27 2013-07-09 Eisai R&D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060159753A1 (en) * 2004-12-27 2006-07-20 Eisai Co. Ltd. Matrix type sustained-release preparation containing basic drug or salt thereof
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
KR100678421B1 (en) * 2005-02-11 2007-02-02 주식회사 씨티씨바이오 Controlled-release formulation containing tamsulosin hydrochloride
WO2006118265A1 (en) * 2005-04-28 2006-11-09 Eisai R & D Management Co., Ltd. Composition containing antidementia agent
CN1895241B (en) * 2005-07-12 2010-05-12 可隆制药株式会社 Composition of long-acting oral pills of Yansuan Tanshuluoxin and its production method
WO2007017253A1 (en) * 2005-08-10 2007-02-15 Add Advanced Drug Delivery Technologies Ltd. Oral preparation with controlled release of a benzenesulphonamide
KR20070021806A (en) * 2005-08-19 2007-02-23 (주)아모레퍼시픽 Sustained-release pellet formulation of ?1-receptor antagonist and process for the preparation thereof
KR20070044911A (en) * 2005-10-26 2007-05-02 주식회사 씨티씨바이오 Controlled-release formulation containing tamsulosin hydrochloride
WO2007131804A1 (en) * 2006-05-17 2007-11-22 Synthon B.V. Tablet composition with a prolonged release of tamsulosin
US20090004284A1 (en) * 2007-06-26 2009-01-01 Watson Pharmaceuticals, Inc. Controlled release tamsulosin hydrochloride formulation
EP2042169A1 (en) * 2007-09-26 2009-04-01 LEK Pharmaceuticals D.D. Controlled release tamsulosin hydrochloride tablets and a process of making them
TWI478712B (en) 2008-09-30 2015-04-01 Astellas Pharma Inc Pharmaceutical composition for modified release
US8465770B2 (en) * 2008-12-24 2013-06-18 Synthon Bv Low dose controlled release tablet
PT2554168T (en) 2010-03-29 2018-02-28 Astellas Pharma Inc Controlled release pharmaceutical composition
RU2593771C2 (en) 2010-04-30 2016-08-10 Такеда Фармасьютикал Компани Лимитед Enteric-coated tablet
AU2012259803B2 (en) * 2011-05-25 2016-03-17 Taiho Pharmaceutical Co., Ltd. Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
CN102579392A (en) * 2012-03-30 2012-07-18 重庆科瑞制药(集团)有限公司 Slow-release preparation containing tamsulosin hydrochloride and preparation method thereof
WO2017186598A1 (en) 2016-04-25 2017-11-02 Synthon B.V. Modified release tablet composition comprising mirabegron
US10478399B2 (en) 2017-10-12 2019-11-19 Synthon B.V. Modified release tablet composition comprising mirabegron
CA3078568A1 (en) 2017-10-12 2019-04-18 Synthon B.V. Modified release tablet composition comprising mirabegron
EP3292864A1 (en) 2017-10-12 2018-03-14 Synthon B.V. Modified release tablet composition comprising mirabegron
WO2019076966A1 (en) 2017-10-17 2019-04-25 Synthon B.V. Tablets comprising tamsulosin and solifenacin

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
EP0205336B1 (en) * 1985-06-11 1991-09-11 Teijin Limited Oral sustained release pharmaceutical preparation
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
IE60311B1 (en) * 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
JPH08502977A (en) * 1992-11-04 1996-04-02 セプラコア，インコーポレイテッド Method for treating benign prostatic hyperplasia and atherosclerosis and (+) doxazosin composition
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
AU7085194A (en) * 1993-07-14 1995-02-13 Yamanouchi Pharmaceutical Co., Ltd. Remedy for urination disorder accompanying prostatic hypertrophy
US5576014A (en) * 1994-01-31 1996-11-19 Yamanouchi Pharmaceutical Co., Ltd Intrabuccally dissolving compressed moldings and production process thereof
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
JPH09323926A (en) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd Sustained release tablet of sodium valproate
AU7888298A (en) * 1997-01-03 1998-07-31 Elan Corporation, Plc Sustained release cisapride minitablet formulation
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
JP4221068B2 (en) * 1997-12-17 2009-02-12 興和創薬株式会社 Theophylline sustained release tablet and method for producing the same
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
TW536402B (en) * 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
JP2000080032A (en) * 1998-06-26 2000-03-21 Yamanouchi Pharmaceut Co Ltd Remedy for excretion disorder
JP2000128774A (en) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd Production of globular, fine grain including medicine
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
BR0009437A (en) * 1999-03-31 2002-01-15 Janssen Pharmaceutica Nv Pre-gelatinized starch in a controlled release formulation
JP2003500348A (en) * 1999-05-20 2003-01-07 エラン コーポレーシヨン ピーエルシー Multiparticulate controlled release selective serotonin reuptake inhibitor formulation
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
EP1203582A4 (en) * 1999-08-09 2005-08-03 Yamanouchi Pharma Co Ltd Medicinal compositions for treating lower uropathy
JP3154710B1 (en) * 1999-08-09 2001-04-09 山之内製薬株式会社 Lower urinary tract disorders
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the manufacture of a medicament for the treatment of benign prostatic hyperplasia
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
US6368628B1 (en) * 2000-05-26 2002-04-09 Pharma Pass Llc Sustained release pharmaceutical composition free of food effect
US6287599B1 (en) * 2000-12-20 2001-09-11 Shire Laboratories, Inc. Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
DE10109763A1 (en) * 2001-02-28 2002-09-05 Gruenenthal Gmbh Pharmaceutical salts
MXPA03000985A (en) * 2001-07-27 2004-04-02 Yamanouchi Pharma Co Ltd Compositions containing sustained-release fine grains for tablets quickly disintegrable in the oral cavity and process for producing the same.
RU2311903C2 (en) † 2001-11-07 2007-12-10 Синтон Б.В. Tamzulosin tablets

Similar Documents

Publication Publication Date Title
AU2002301845A1 (en) Modified release tamsulosin tablets
HUP0402004A3 (en) Modified release tamsulosin tablets
AU2002327068A1 (en) Immediate release tablet
AU2003262059A1 (en) Sustained release preparation
AU2003241483A1 (en) Push release loop
AU2002359414A1 (en) Interposer
AU2002315779A1 (en) Soft capsules
AU2002363360A1 (en) Dual controlled release dosage form
AU2003219814A1 (en) Release agents
AUPR951501A0 (en) Modified sustained release pharmaceutical system
AU2002359382A1 (en) Quick release assembly
AU2002343227A1 (en) Modified release tamsulosin tablets
AU2002301844B2 (en) Tamsulosin tablets
AU2002301844A1 (en) Tamsulosin tablets
AU2002341442A1 (en) Tamsulosin tablets
AU2003229163A1 (en) Extended release tablets comprising felodipine
AU2002347776A1 (en) Modified release dosage forms
AU2002334731A1 (en) Modified release dosage forms
AU2002334741A1 (en) Modified release dosage forms
AU2002341502A1 (en) Release device
AUPR284701A0 (en) Release mechanism
AU2002354571A1 (en) Tablet cryotechnology
AU2002302841A1 (en) Capsules
AU2002323447A1 (en) Sustained release preparations
AU2002233436A1 (en) Fenofibrate tablets